Search Results - "Denapiene, G."

Randomised clinical trial: the efficacy and safety of propionyl‐l‐carnitine therapy in patients with ulcerative colitis receiving stable oral treatment by Mikhailova, T. L., Sishkova, E., Poniewierka, E., Zhidkov, K. P., Bakulin, I. G., Kupcinskas, L., Lesniakowski, K., Grinevich, V. B., Malecka‐Panas, E., Ardizzone, S., D’Arienzo, A., Valpiani, D., Koch, M., Denapiene, G., Vago, G., Fociani, P., Zerbi, P., Ceracchi, M., Camerini, R., Gasbarrini, G.

“…Aliment Pharmacol Ther 2011; 34: 1088–1097 Summary Background  Ulcerative colitis (UC) is characterised by impaired fatty‐acid oxidation; l‐carnitine has a key…”
Get full text

P686 Thiopurine methyltransferase polymorphism in Lithuanian inflammatory bowel disease patients by Kupcinskas, J., Steponaitiene, R., Kiudelis, G., Denapiene, G., Valantinas, J., Jonaitis, L., Kupcinskas, L., Skieceviciene, J.

Get full text

P685 Ulcerative colitis risk loci in Lithuanian-Latvian case control sample – a replication study by Skieceviciene, J., Kupcinskas, L., Jonaitis, L., Zvirbliene, A., Denapiene, G., Valantinas, J., Leja, M., Derovs, A., Kiudelis, G., Schreiber, S., Franke, A.

Get full text

Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment: Randomised clinical trial: propionyl-l-carnitine in ulcerative colitis by Mikhailova, T. L., Sishkova, E., Poniewierka, E., Zhidkov, K. P., Bakulin, I. G., Kupcinskas, L., Lesniakowski, K., Grinevich, V. B., Malecka-Panas, E., Ardizzone, S., D’Arienzo, A., Valpiani, D., Koch, M., Denapiene, G., Vago, G., Fociani, P., Zerbi, P., Ceracchi, M., Camerini, R., Gasbarrini, G.

Get full text

Evaluation of Gastroduodenal Disorders in NSAID Users due to Helicobacter pylori Status by Denapiene, G, Irnius, A, Venalis, A, Barakauskiene, A, Buineviciute, A, Cepuliene, I

Get full text